0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Intermediates Market by Type, Application, Process Type, End User - Global Forecast to 2030- Product Image
Pharmaceutical Intermediates Market by Type, Application, Process Type, End User - Global Forecast to 2030- Product Image
Sale

Pharmaceutical Intermediates Market by Type, Application, Process Type, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968712
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Pharmaceutical intermediates form the essential link between raw materials and finished pharmaceutical products, playing a critical role in enabling innovation, efficiency, and compliance across therapeutic pipelines. Senior leaders navigating this market must understand the evolving ecosystem underpinning both product development and operational resilience.

Market Snapshot: Pharmaceutical Intermediates Market Overview

The Pharmaceutical Intermediates Market grew from USD 33.99 billion in 2024 to USD 36.86 billion in 2025. It is expected to continue growing at a CAGR of 8.22%, reaching USD 54.60 billion by 2030. Market expansion is propelled by rising demand for high-purity intermediates and the adoption of advanced production technologies. Increasing regulatory scrutiny and the need for agile supply chains are shaping investment priorities for global manufacturers and stakeholders who want to capture growing opportunities in this dynamic space.

Scope & Segmentation

  • Compound Types: Antibiotics (including beta lactam, macrolide, quinolone, tetracycline subclasses), hormones, peptides, steroids, vitamins
  • Applications: Anti-diabetic, anti-infective, cardiovascular, central nervous system, oncology (encompassing cytotoxic, hormonal therapy, immunotherapy, and targeted therapy compounds)
  • Process Methodologies: Biocatalysis, chemical synthesis, and fermentation (via bacterial, fungal, or yeast platforms)
  • End Users: Contract manufacturing organizations, pharmaceutical companies, research organizations
  • Regions Covered: Americas (with detailed US state-level focus), Europe, Middle East & Africa (including leading economies and emerging healthcare hubs), Asia-Pacific (emphasizing cost-efficient manufacturing centers and robust domestic R&D activity)
  • Companies Profiled: Lonza Group AG, Evonik Industries AG, Merck KGaA, BASF SE, Cambrex Corporation, Wuxi AppTec Co., Ltd., Albemarle Corporation, Johnson Matthey PLC, Zhejiang Huahai Pharmaceutical Co., Ltd., Hubei Biocause Pharmaceutical Co., Ltd.

Key Takeaways for Senior Decision-Makers

  • Process innovation, such as continuous flow chemistry and hybrid synthesis, is redefining pharmaceutical intermediate manufacturing, enabling greater efficiency and flexibility.
  • Regulatory modernization and Quality by Design principles are setting higher compliance benchmarks; adopting real-time monitoring and advanced analytics is supporting consistent batch quality.
  • Strategic partnerships between chemical manufacturers and biotechnology firms are fostering access to novel enzyme libraries and driving speed in commercial-scale transitions.
  • Supply chain sustainability is increasingly pivotal, with digital platforms enabling end-to-end visibility and supporting environmental and transparency objectives.
  • Regional market approaches must reflect local regulatory environments, production strengths, and evolving investment climates—for example, the Asia-Pacific’s expansion in value-added intermediates and Americas’ focus on biologics and rapid therapy development.
  • Competitive advantage hinges on service flexibility and rapid scaling, as well as technical expertise and digital supply chain integration.

Tariff Impact: Navigating Policy-Driven Shifts in Supply Chains

Recent US tariffs on select pharmaceutical intermediates have increased import costs for organizations sourcing from specific regions. Manufacturers are reevaluating supplier networks, shifting towards nearshoring and domestic capacity to safeguard margins and maintain production continuity. The evolving tariff environment has also accelerated the adoption of predictive analytics in inventory management and prompted risk-sharing models with raw material partners. For executives, proactively adapting sourcing strategies and investing in flexible facilities are now critical to mitigate policy risks and leverage emerging regional advantages.

Methodology & Data Sources

Insights in this market analysis are supported by primary interviews with key supply chain executives, regulatory specialists, and R&D leaders, alongside a thorough review of published industry data, regulatory filings, patent resources, and company reports. Cross-validation and peer-review processes ensure analytical rigor and actionable findings for all stakeholders.

Why This Report Matters

  • Empowers leaders to identify and capitalize on growth opportunities through a clear view of segmentation, competitor strategies, and regional trends in the pharmaceutical intermediates market.
  • Provides evidence-based recommendations for optimizing sourcing strategies, aligning operations with regulatory expectations, and integrating digital solutions for resilience.
  • Delivers a practical framework to guide investment decisions, risk mitigation, and market entry or expansion planning in a changing global context.

Conclusion

The pharmaceutical intermediates market stands at the intersection of technological innovation, regulatory complexity, and shifting global trade policies. Executives prepared to build adaptive, sustainable operations will be best positioned to excel in this evolving environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pharmaceutical Intermediates Market, by Type
8.1. Introduction
8.2. Antibiotic
8.2.1. Beta Lactam
8.2.2. Macrolide
8.2.3. Quinolone
8.2.4. Tetracycline
8.3. Hormone
8.4. Peptide
8.5. Steroid
8.6. Vitamin
9. Pharmaceutical Intermediates Market, by Application
9.1. Introduction
9.2. Anti Diabetic
9.3. Anti Infective
9.4. Cardiovascular
9.5. Central Nervous System
9.6. Oncology
9.6.1. Cytotoxic
9.6.2. Hormonal Therapy
9.6.3. Immunotherapy
9.6.4. Targeted Therapy
10. Pharmaceutical Intermediates Market, by Process Type
10.1. Introduction
10.2. Biocatalysis
10.3. Chemical Synthesis
10.4. Fermentation
10.4.1. Bacterial
10.4.2. Fungal
10.4.3. Yeast
11. Pharmaceutical Intermediates Market, by End User
11.1. Introduction
11.2. Contract Manufacturing Organizations
11.3. Pharmaceutical Companies
11.4. Research Organizations
12. Americas Pharmaceutical Intermediates Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Pharmaceutical Intermediates Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Pharmaceutical Intermediates Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Lonza Group AG
15.3.2. Evonik Industries AG
15.3.3. Merck KGaA
15.3.4. BASF SE
15.3.5. Cambrex Corporation
15.3.6. Wuxi AppTec Co., Ltd.
15.3.7. Albemarle Corporation
15.3.8. Johnson Matthey PLC
15.3.9. Zhejiang Huahai Pharmaceutical Co., Ltd.
15.3.10. Hubei Biocause Pharmaceutical Co., Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. PHARMACEUTICAL INTERMEDIATES MARKET MULTI-CURRENCY
FIGURE 2. PHARMACEUTICAL INTERMEDIATES MARKET MULTI-LANGUAGE
FIGURE 3. PHARMACEUTICAL INTERMEDIATES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PHARMACEUTICAL INTERMEDIATES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PHARMACEUTICAL INTERMEDIATES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. PHARMACEUTICAL INTERMEDIATES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY BETA LACTAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY MACROLIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY QUINOLONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TETRACYCLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY HORMONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PEPTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY STEROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY VITAMIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTI DIABETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTI INFECTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY CYTOTOXIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY HORMONAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY BIOCATALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FUNGAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY YEAST, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 56. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 58. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 60. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 61. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 62. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 65. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 67. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 68. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 69. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 101. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 103. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 104. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 105. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 108. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 110. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 111. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 112. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 122. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 124. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 125. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 126. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 129. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 131. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 132. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 133. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 143. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 145. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 146. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 147. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 150. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 152. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 153. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 154. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 157. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 159. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 160. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 161. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. QATAR PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 170. QATAR PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 171. QATAR PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. QATAR PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 173. QATAR PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 174. QATAR PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 175. QATAR PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. FINLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. FINLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 178. FINLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. FINLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 180. FINLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 181. FINLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 182. FINLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 185. SWEDEN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. SWEDEN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 187. SWEDEN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 188. SWEDEN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 189. SWEDEN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. NIGERIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 192. NIGERIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. NIGERIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 194. NIGERIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 195. NIGERIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 196. NIGERIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. EGYPT PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 198. EGYPT PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 199. EGYPT PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. EGYPT PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 201. EGYPT PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 202. EGYPT PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 203. EGYPT PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. TURKEY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 205. TURKEY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 206. TURKEY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. TURKEY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 208. TURKEY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 209. TURKEY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 210. TURKEY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. NORWAY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 219. NORWAY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 220. NORWAY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. NORWAY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 222. NORWAY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 223. NORWAY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 224. NORWAY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. POLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 226. POLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 227. POLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. POLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 229. POLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 230. POLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 231. POLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 233. SWITZERLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 234. SWITZERLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. SWITZERLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 236. SWITZERLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 237. SWITZERLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 238. SWITZERLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 245. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 247. CHINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 248. CHINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 249. CHINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. CHINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 251. CHINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 252. CHINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 253. CHINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. INDIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 255. INDIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 256. INDIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. INDIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 258. INDIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 259. INDIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 260. INDIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. JAPAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 262. JAPAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 263. JAPAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. JAPAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 265. JAPAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 266. JAPAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 267. JAPAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 272. AUSTRALIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 273. AUSTRALIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 274. AUSTRALIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 277. SOUTH KOREA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. SOUTH KOREA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 279. SOUTH KOREA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 280. SOUTH KOREA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 281. SOUTH KOREA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. INDONESIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 286. INDONESIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 287. INDONESIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 288. INDONESIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. THAILAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 290. THAILAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 291. THAILAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. THAILAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 293. THAILAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 294. THAILAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 295. THAILAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 296. PHILIPPINES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 297. PHILIPPINES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 298. PHILIPPINES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. PHILIPPINES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 300. PHILIPPINES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 301. PHILIPPINES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 302. PHILIPPINES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 305. MALAYSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. MALAYSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 307. MALAYSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 308. MALAYSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 309. MALAYSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. SINGAPORE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 311. SINGAPORE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 312. SINGAPORE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. SINGAPORE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 314. SINGAPORE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 315. SINGAPORE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 316. SINGAPORE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. VIETNAM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 318. VIETNAM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTIC, 2018-2030 (USD MILLION)
TABLE 319. VIETNAM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. VIETNAM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 321. VIETNAM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PROCESS TYPE, 2018-2030 (USD MILLION)
TABLE 322. VIETNAM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 323. VIETNAM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 324. TAIWAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE,

Samples

Sample File DOWNLOAD NOW

Companies Mentioned

The companies profiled in this Pharmaceutical Intermediates market report include:
  • Lonza Group AG
  • Evonik Industries AG
  • Merck KGaA
  • BASF SE
  • Cambrex Corporation
  • Wuxi AppTec Co., Ltd.
  • Albemarle Corporation
  • Johnson Matthey PLC
  • Zhejiang Huahai Pharmaceutical Co., Ltd.
  • Hubei Biocause Pharmaceutical Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 36.86 Billion
Forecasted Market Value ( USD ) by 2030 $ 54.6 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Pharmaceutical Intermediates - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Pharmaceutical Intermediates - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 110 Pages
  • Global
From
EUR$4,750USDGBP
Active Pharmaceutical Ingredients CDMO Market by Service Type, Molecule Type, Production Scale, Therapeutic Area, Manufacturing Technology - Global Forecast to 2030 - Product Image

Active Pharmaceutical Ingredients CDMO Market by Service Type, Molecule Type, Production Scale, Therapeutic Area, Manufacturing Technology - Global Forecast to 2030

  • Report
  • 181 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
API Intermediates Market by Product Type, Application, End User, Organization Size, Deployment Type, Distribution Channel, Pricing Model - Global Forecast to 2030 - Product Image

API Intermediates Market by Product Type, Application, End User, Organization Size, Deployment Type, Distribution Channel, Pricing Model - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Benzylamine Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application - Product Image

Benzylamine Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

  • Report
  • 84 Pages
  • Global
From
EUR$4,240USDGBP
Pharmaceutical Intermediates Market Report 2025 - Product Image

Pharmaceutical Intermediates Market Report 2025

  • Report
  • 200 Pages
  • Global
From
EUR$4,490USDGBP

About the Pharmaceutical Intermediates Market

The Pharmaceutical Intermediates market is a segment of the pharmaceutical industry that focuses on the production of intermediate compounds used in the manufacture of drugs. These intermediates are typically produced in bulk and are used in the synthesis of active pharmaceutical ingredients (APIs). Pharmaceutical intermediates are typically produced in large quantities and are used in the production of a wide range of drugs, including antibiotics, antifungals, antivirals, and anti-inflammatory agents. The Pharmaceutical Intermediates market is highly competitive, with many companies offering a wide range of products. Some of the major players in the market include Merck, Pfizer, Novartis, Sanofi, and GlaxoSmithKline. These companies are involved in the production of a variety of intermediates, including amino acids, peptides, carbohydrates, and lipids. Additionally, many of these companies are involved in the development of new intermediates for the production of novel drugs. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more